BIOCHEMICAL SOCIETY TRANSACTIONS
Centre and purified using the appropriate Synsorbs (Chembiomed Ltd., Alberta, Canada). Monoclonal anti-A was isolated in the M.R.C. Human Biochemical Genetics Unit. In one experiment lactase from two individuals of different blood group (A and 0) was purified by immunoaffinity chromatography as described in Potter et al. (1985) .
Using the A blood-group specific antibodies and the lectin from Helix pomutiu we have shown that many different glycoproteins from five A secretors, one AB secretor and one (out of four) apparent A non-secretors carry abundant A antigen, and that the antigen is specifically carried on lactase, sucrase and aminopeptidase. Likewise the anti-B serum and the lectin from Bandeiraea sirnplic$olia (BS 1 ) reveal that the B antigen is carried on the glycoproteins of all seven B secretors and the one AB secretor tested, and can be demonstrated specifically on the lactase, sucrase and aminopeptidase. No B non-secretors were available for study. Using anti-H serum and the lectin from Wlex europeaus, quantitative differences could be seen in the H antigen detected on these glycoproteins in secretors and non-secretors but this was less clear cut. Similar experiments in progress with anti-Lewis antibodies show that Le" and/or Le" are carried on this group of glycoproteins and can be specifically detected on sucrase, lactase and aminopeptidase. The presence of the Lewis antigens on the glycoproteins of the samples so far tested appears also to depend on the ABO, Lewis and secretor types of the individuals as expected.
Thus our results confirm those of Triadou et ul. (1983) that the ABH antigens are structural determinants on the brush-border hydrolases of the human small intestine. This expression also appears to be dependent upon the secretor status, although there was one exception, an individual whose brush-border hydrolases carry the A determinant despite the lack of a-2-fucosyltransferase activity in the jejunum and their non-secretor status as judged by stomach mucus. This discrepancy is not easily explained by the quality of the post-mortem tissue, particularly since the levels of the a-3-~-acetylgalactosaminyltransferase and a-3-fucosyltransferase were both high. I t is known that the presence of the H antigen in certain human intestinal cells is not under the control of the Se gene (Mollicone et al., 1986) and it is possible that a-2-fucosyltransferase activities are present in the human gut which are not detectable by our standard assay procedures. It is intriguing but possibly coincidental that this exceptional individual was also Lewis negative.
Although jejunal aminopeptidase carries the ABH and Lewis determinants, aminopeptidase from kidney, which is a closely related enzyme, and probably a product of the same gene locus, does not. It is noteworthy that the overall level of a-2-fucosyltransferase in kidney is low in comparison with jejunum, suggesting that this enzyme may not be expressed within the cells responsible for the synthesis of aminopeptidase.
We acknowledge the valuable assistance of Jean Noades and Ira Islam. We are grateful for the ICRF fellowship awarded to P.G. We thank Dr. Winifrcd Watkins fur her helpful advice. Clinical trials in the U.K. using highly purified preparations of hyaluronidase have shown that the enzyme has some beneficial effect in the treatment of myocardial infarction (Flint ot ul., 1982; Henderson et al., 1982; Saltissi et al., 1982) . However, there is considerable speculation as to the therapeutic mechanism of action of this enzyme (Maroko rt ul., 1977) . Recent studies with '251-labelled hyaluronidase have shown that enzyme, intravenously administered to the rat, is preferentially taken up by the liver (Earnshaw et al., 198%) ; however, only 0.1 YO of the hyaluronidase is accumulated by the heart. Interestingly, studies using animals with induced myocardial infarction have shown that there is a preferential uptake of labelled hyaluronidase by the damaged myocardium as compared with normal heart tissue (Earnshaw el al., 198%).
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The use of '251-labelled hyaluronidase has precluded the use of autoradiographic methods for the specific localization of the enzyme within tissues. Also, the use of '251-label may result in an anomalous distribution of enzyme within the whole animal and consequently a second method for the detection of enzyme would be desirable. In this paper we describe a method for the preparation of a biotinylated derivative of hyaluronidase. This preparation, in conjunction with appropriate streptavidin-conjugates (e.g. fluoresceinlabelled streptavidin), will allow us to determine the sites of accumulation of the biotin-labelled hyaluronidase at the organ, cellular and subcellular levels.
Bovine testicular hyaluronidase ( > 40 000 i.u./mg; Humphrey, 1957) was purified by the methods of Pope et al. (1976) and Gorham (1974) . Enzyme activity was assayed by the method of Gacesa et al. (1981) . Hyaluronidase was modified with biotinyl N-hydroxysuccinimide ester (BNHS) essentially by the method of Guesdon et al. (1979) . Typically, hyaluronidase (1.2mg) was dissolved in 0.48ml of 0.1 MNaHCO,, pH 8.3, to which 48 p1 of N,N-dimethylfonnamide containing an appropriate quantity of BNHS had been added. The mixture was left for 4 h at 25°C before separation of the biotin-labelled enzyme from free biotin and BNHS by gel-permeation chromatography (Fig. I) . 
unreacted B N H S b.y gel-permeation chromatography
Samples of the reaction mixture (0.2ml) were applied to a column of Sephadex G25 (superfine: 0.9cm x 30cm) and eluted with 0. I M-NaCI at a flow rate of 50 pl/min. Fractions (0.75 ml) were analysed for protein ( o), radioactivity, (A) and hyaluronidase activity (B).
ried out under identical conditions but with the addition of d-[8,9-'H]biotin succinimide ester (Amersham, final sp. activity 464 mCi/mmol). Portions of each fraction were analysed for radioactivity, hyaluronidase activity and protein content.
In initial experiments using a 10-fold molar excess of BNHS to protein (a ratio of 0.19 rnol of BNHS/mol of lysine residues) low quantities of biotin were covalently bound to the enzyme: only 0.02% of lysine residues were modified (0.01 mol/mol of protein). This was disappointing, as a published method using reactant ratios of this order (a ratio of 0.05-0.10mol of BNHS/mol of amino groups) yielded between 1.4 and 26% modification of amino groups of various proteins (Guesdon et al., 1979) . We were able to repeat this observation in our laboratories using bovine serum albumn (BSA) where a 3 : 1 molar ratio of BNHS to BSA (approx. 0.03 mol of BNHS/mol of amino groups) was used which yielded a modification of approx. 2.2% of amino groups ( 1.3 rnol of biotin/mol of protein). When a 400-fold molar excess of BNHS to hyaluronidase protein was used (a ratio of 0.6mol of BNHS/per rnol of lysine residues) preparations of enzyme containing approx. 5 rnol of biotin/mol enzyme (8.3% of total lysine residues) were routinely obtained.
Absolute concentrations of reactants had a negligible effect on the extent of incorporation of biotin providing that the stoichiometry was held constant. Some loss of hyalurondase activity (approx. 30%) occurred when high molar excesses (400-fold) of BNHS were used. However, the use of less BNHS resulted in little or no inactivation of the ezyme.
It is clear from our results that higher concentrations of BNHS than those used conventionally are necessary to achieve sufficient labelling of hyaluronidase. This result is surprising as hyaluronidase contains 54 rnol of lysine residues/mol of enzyme (Borders & Raftery, 1968) , a value similar to that for BSA, and therefore there is no shortage of potential sites for the covalent attachment of biotin.
In conclusion, bovine testicular hyaluronidase has been modified by the covalent attachment of typically 5 rnol of biotin/mol of enzyme. This preparation will be used in pharmacological studies to determine the localization of the intravenously injected enzyme at the organ, cellular and subcellular levels.
previous experiments have shown that during cell-to-cell contact, normal lymphocytes transferred certain lysosomal enzymes to fibroblasts obtained from patients deficient in each of the respective lysosomal enzymes (Olsen et al., 1982 (Olsen et al., , 1983 . Moreover, the activities of these enzymes in the donor lymphocytes did not decrease when they were co-cultured with the fibroblasts but instead were far higher than the comparable activities in lymphocytes cultured alone (Olsen et al., 1982 (Olsen et al., , 1983 . Thus cell contact either stimulated lysosomal enzyme activity in the lymphocytes or induced the synthesis de novo of new enzyme. Although the precise mechanism is not yet known, successful enzyme transfer to the fibroblasts was dependent on this increase in activity
